These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2906709)

  • 1. [Effects of a new alpha- and beta-adrenoceptor blocking drug (YM-09538) on intraoperative hypertension].
    Sha K; Furuya H; Kuro M; Kitaguchi K; Yamagishi N; Marunaka S; Shimoyama J; Okuda T
    Masui; 1988 Jul; 37(7):830-5. PubMed ID: 2906709
    [No Abstract]   [Full Text] [Related]  

  • 2. Labetalol, a new alpha- and beta-adrenoreceptor blocking agent, in hypertension.
    Hansson L; Hänel B
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):763-4. PubMed ID: 10952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hypertensive emergencies: clinical evaluation of the use of a new drug: labetalol hydrochloride].
    Rossano P; Saffiotti O; Mayer MC; Blasich M; Rossano G; Bellotti P
    Minerva Cardioangiol; 1980 May; 28(5):309-14. PubMed ID: 6111048
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effects of alpha-and beta-adrenoceptor blocking agent (YM-09538) upon the clinical features of a patient with pheochromocytoma].
    Matsuura H; Koyama S; Tsuchioka Y; Yoshida M; Kurogane H
    Horumon To Rinsho; 1982 Dec; 30(12):1439-46. PubMed ID: 6130862
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of mild and moderate hypertension with medroxalol, an alpha- and beta-adrenergic antagonist.
    Schechter PJ; Tanskanen A; Tuomilehto J; Koch-Weser J
    J Cardiovasc Pharmacol; 1982; 4(6):955-9. PubMed ID: 6185788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Proxodolol--a new beta- and alpha-adrenoblockader].
    Iuzhakov SD; Dolgun OV; Dorodnikova EV; Aniukhovskiĭ EP; Baldenkov GN; Rozenshtraukh LV; Medvedev OS; Mashkovskiĭ MD
    Eksp Klin Farmakol; 1994; 57(3):30-3. PubMed ID: 7914115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Labetalol therapy in patients with systemic hypertension and angina pectoris: effects of combined alpha and beta adrenoceptor blockade.
    Frishman WH; Strom JA; Kirschner M; Poland M; Klein N; Halprin S; LeJemtel TH; Kram M; Sonnenblick EH
    Am J Cardiol; 1981 Nov; 48(5):917-28. PubMed ID: 6118060
    [No Abstract]   [Full Text] [Related]  

  • 8. Labetalol, an alpha- and beta-adrenergic blocking drug in the treatment of hypertension.
    Rosei EA; Fraser R; Morton JJ; Brown JJ; Lever AF; Robertson JI; Trust PM
    Am Heart J; 1977 Jan; 93(1):124-5. PubMed ID: 12654
    [No Abstract]   [Full Text] [Related]  

  • 9. Combined labetalol plus flunarizine treatment for arterial hypertension.
    Bonavita E
    Int J Clin Pharmacol Res; 1984; 4(6):475-80. PubMed ID: 6152439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeutic effect of trandat, an alpha- and beta-adrenergic receptor blockader, and its effect on central, regional and intracardiac hemodynamics].
    Erina EV; Charyev KhE; Beliakova EV; Tverskaia LV; Kukharchuk VV
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1982; 5(1):68-74. PubMed ID: 6124260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The pharmacodynamic and hypotensive efficacy of proxodolol in an acute drug test on hypertension patients].
    Kukes VG; Starodubtsev AK; Smirnov MV; Petrov IN
    Eksp Klin Farmakol; 1994; 57(3):45-7. PubMed ID: 7914120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [alpha and beta Blockaders for the management of hypertension].
    Tsukiyama H; Ohtsuka K
    Nihon Rinsho; 1984 Feb; 42(2):416-21. PubMed ID: 6143840
    [No Abstract]   [Full Text] [Related]  

  • 13. [Combined alpha and beta adrenergic receptor blockade in the treatment of renal hypertension].
    Stummvoll HK
    Wien Med Wochenschr Suppl; 1981; 69():14-6. PubMed ID: 6123200
    [No Abstract]   [Full Text] [Related]  

  • 14. [Beta and alpha-adrenoceptor blockers in the planning of anti-hypertensive therapy: recommendations for general practice].
    Bühler FR; Bolli P; Hulthén L; Amann FW
    Ther Umsch; 1981; 38 Suppl():17-23. PubMed ID: 6122284
    [No Abstract]   [Full Text] [Related]  

  • 15. [The new Russian preparation proxodolol in the treatment of arterial hypertension].
    Ol'binskaia LI; Morozova TE
    Eksp Klin Farmakol; 1994; 57(3):42-5. PubMed ID: 7914119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined alpha- and beta-adrenergic blockade in the treatment of hypertension: myth or reality? Workshop held in Corsendonck (Belgium) on February 28, 1981.
    J Cardiovasc Pharmacol; 1981; 3 Suppl 1():S1-74. PubMed ID: 6169955
    [No Abstract]   [Full Text] [Related]  

  • 17. A study of labetalol, a new alpha- and beta-adrenoceptor blocking agent, in humans.
    Vas A; Gachályi B; Káldor A
    Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):491-2. PubMed ID: 7141757
    [No Abstract]   [Full Text] [Related]  

  • 18. Adrenoceptor blockade in hypertension. A symposium of Glaxo, Sweden, Skövde, 8-9 October, 1981.
    Acta Med Scand Suppl; 1982; 665():1-147. PubMed ID: 6130672
    [No Abstract]   [Full Text] [Related]  

  • 19. Review of the use of alpha-adrenoceptor antagonists in hypertension.
    Stokes GS; Marwood JF
    Methods Find Exp Clin Pharmacol; 1984 Apr; 6(4):197-204. PubMed ID: 6146746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Reflexions on drug therapy of arterial hypertension. Rational therapy].
    Cocco G; Strozzi C; Padula A; Al Yassini K
    Minerva Cardioangiol; 1984 Dec; 32(12):929-40. PubMed ID: 6152333
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.